[Stoutness and prognosis of female non-metastatic breast cancer: results from a French observational cohort study]
- PMID: 19467984
- DOI: 10.1684/bdc.2009.0856
[Stoutness and prognosis of female non-metastatic breast cancer: results from a French observational cohort study]
Abstract
Aim: Our objective was to study the prognostic value of stoutness in non-metastatic breast cancer, from a population of French women.
Methods: We constituted a large observational cohort of patients followed since a first unilateral breast cancer without distant dissemination. Stoutness was assessed using the body mass index (BMI, in kg/m(2)) at the time of diagnosis. Patients were classified into the four main categories of BMI, defined according to the World Health Organization recommendations. The risk of prognosis events was analyzed according to the BMI categories. To this end, survival analyses were achieved.
Results: The patients having a BMI value of at least 25 kg/m(2) presented significantly higher risks of death and metastasis recurrences when they were compared to the patients having a normal value of BMI. The multivariate analyses found a modest increase of risk, about 10 to 20%, depending on the degree of fatness. It reached about 20 to 50% according to the univariate analyses. The obese patients (BMI >or= 30 kg/m(2)) had an increase of 50% of the risk of second primary cancers, comparatively to the patients having a normal value of BMI. Regarding contralateral, nodal and local recurrences, the survival analyses did not achieve any significant relationship with stoutness.
Conclusion: A poorer prognosis is observed when breast cancer patients have a value of BMI that matches at least with overweight. Contrary to the results of few recent surveys, underweight patients do not present a poorer prognosis than normal weight patients. Excess of weight represents a modifiable factor in order to improve female breast cancer prognosis.
Similar articles
-
Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points.Breast Cancer Res Treat. 2009 May;115(1):193-203. doi: 10.1007/s10549-008-0065-7. Epub 2008 Jun 12. Breast Cancer Res Treat. 2009. PMID: 18546073
-
Is obesity an independent prognosis factor in woman breast cancer?Breast Cancer Res Treat. 2008 Sep;111(2):329-42. doi: 10.1007/s10549-007-9785-3. Epub 2007 Oct 16. Breast Cancer Res Treat. 2008. PMID: 17939036
-
Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.Breast Cancer Res Treat. 2012 Apr;132(2):729-39. doi: 10.1007/s10549-011-1914-3. Epub 2011 Dec 21. Breast Cancer Res Treat. 2012. PMID: 22187127 Free PMC article.
-
Obesity in breast cancer--what is the risk factor?Eur J Cancer. 2015 Apr;51(6):705-20. doi: 10.1016/j.ejca.2015.01.057. Epub 2015 Mar 3. Eur J Cancer. 2015. PMID: 25747851 Review.
-
Early breast cancer: why does obesity affect prognosis?Proc Nutr Soc. 2018 Nov;77(4):369-381. doi: 10.1017/S0029665118000447. Epub 2018 Jun 4. Proc Nutr Soc. 2018. PMID: 29860965 Review.
Cited by
-
Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells.Cancer Biol Ther. 2015;16(8):1220-30. doi: 10.1080/15384047.2015.1056409. Epub 2015 Jun 29. Cancer Biol Ther. 2015. PMID: 26121010 Free PMC article.
-
Multifaceted leptin network: the molecular connection between obesity and breast cancer.J Mammary Gland Biol Neoplasia. 2013 Dec;18(3-4):309-20. doi: 10.1007/s10911-013-9308-2. Epub 2013 Nov 10. J Mammary Gland Biol Neoplasia. 2013. PMID: 24214584 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical